Medical device co Nyxoah plunges on $95 mln share sale amid US CEO search
BUZZ-Medical device co Nyxoah plunges on $95 mln share sale amid US CEO search Updates with stock offering price details
** U.S.-listed shares of Belgian medical device maker Nyxoah SA NYXH.O plunge 48.8% to $1.48 and hit record low on Fri as it raises equity amid leadership transition to a U.S.-based CEO
** Co focused on obstructive sleep apnea solutions sells ~55.2 mln shares at $1.72 for $95 mln gross proceeds
** Offering price represents 40.3% discount to stock's last sale on Thurs
** It intends to use net offering proceeds to expand commercialization activities for its Genio system in the U.S., finance R&D and advance commercialization of the system outside of the U.S., among other purposes
** Co said late Thurs its board launched formal search process to appoint a new U.S.-based CEO "who will lead Nyxoah from within a critical market for the Company’s future growth"
** BofA lead bookrunner, joined by Bank Degroof Petercam for equity offering
** Co had ~43.66 mln shares outstanding as of Mar 31, per the prospectus
** With the decline, NYXH shares down ~68% YTD
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
Recent news on Nyxoah SA
See all newsBelgium's Nyxoah Q3 revenue rises on US commercialization
Brief: Nyxoah SA Q3 Gross Profit EUR 5.785 Million
Brief: Nyxoah SA Submits Pma Supplement To FDA To Expand Genio Indication To Complete Concentric Collapse Patients
Brief: Nyxoah Says Co Appoints Liam Kelly As Chief Executive Officer Effective October 1
Brief: Cvrx Appoints John Landry As Chief Financial Officer